# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601830-24-000052
Filing Date
2024-05-09
Accepted
2024-05-09 16:11:55
Documents
77
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | rxrx-20240331.htm iXBRL | 10-Q | 811251
2 | EX-10.1 | exhibit101-viraniadvisorya.htm | EX-10.1 | 67701
3 | EX-10.2 | exhibit102-viranitransitio.htm | EX-10.2 | 127968
4 | EX-31.1 | exhibit311-q0124.htm | EX-31.1 | 7380
5 | EX-31.2 | exhibit312-q0124.htm | EX-31.2 | 7367
6 | EX-32.1 | exhibit321-q0124.htm | EX-32.1 | 3274
12 |  | rxrx-20240331_g1.jpg | GRAPHIC | 97496
13 |  | rxrx-20240331_g2.jpg | GRAPHIC | 226167
| Complete submission text file | 0001601830-24-000052.txt |  | 6660587

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | rxrx-20240331.xsd | EX-101.SCH | 44726
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | rxrx-20240331_cal.xml | EX-101.CAL | 77980
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | rxrx-20240331_def.xml | EX-101.DEF | 233939
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | rxrx-20240331_lab.xml | EX-101.LAB | 605525
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | rxrx-20240331_pre.xml | EX-101.PRE | 415793
81 | EXTRACTED XBRL INSTANCE DOCUMENT | rxrx-20240331_htm.xml | XML | 642449

Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40323 | Film No.: 24930724
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)